Questa traduzione è in preparazione. Nel frattempo mostriamo temporaneamente la versione originale in inglese.
Imprese · 16/09/20021 min di lettura
Agency Information Collection Activities; Submission for OMB Review; Comment Request; Dissemination of Information on Unapproved/New Uses for Marketed Drugs, Biologics, and Devices
Traduzione automatica locale · Lingua originale della fonte
Riepilogo
The Food and Drug Administration (FDA) is announcing that the proposed collection of information entitled "Dissemination of Information on Unapproved/New Uses for Marketed Drugs, Biologics, and Devices has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Lingua originale della fonte: Federal Register — Food and Drug AdministrationApri il comunicato originale →